School of Health Management, Anhui Medical University, Hefei, Anhui, China.
Clin Exp Immunol. 2014 Sep;177(3):557-70. doi: 10.1111/cei.12372.
Numerous studies have suggested the importance of leptin against autoimmune diseases such as systemic lupus erythematosus (SLE), multiple sclerosis (MS) and psoriasis. To summarize our current understanding of the role of leptin in inflammatory responses and rheumatoid arthritis (RA), a systematic review was conducted to assess the discrepancy of leptin in RA and its effect on immunity according to different studies. Recently, emerging data have indicated that leptin is involved in the pathological function of RA, which is common in autoimmune disorders. This review discusses the possible consequences of leptin levels in RA. Blocking the key signal pathways of leptin and inhibiting the leptin activity-like leptin antagonist may be a promising way for potential therapeutic treatment of RA at risk of detrimental effects. However, leptin was increased in patients with RA and may also regulate joint damage. Thus, more understanding of the mechanism of leptin in RA would be advantageous in the future.
大量研究表明瘦素在防治红斑狼疮(SLE)、多发性硬化(MS)和银屑病等自身免疫性疾病中的重要性。为了总结我们目前对瘦素在炎症反应和类风湿关节炎(RA)中的作用的认识,我们进行了一项系统评价,以评估不同研究中 RA 患者瘦素的差异及其对免疫的影响。最近,新出现的数据表明,瘦素参与了 RA 的病理功能,这在自身免疫性疾病中很常见。本文讨论了 RA 中瘦素水平可能产生的后果。阻断瘦素的关键信号通路和抑制类似瘦素拮抗剂的瘦素活性可能是一种有前途的方法,有望对有潜在不良影响的 RA 进行潜在的治疗。然而,RA 患者的瘦素水平升高,也可能调节关节损伤。因此,未来需要更多地了解瘦素在 RA 中的作用机制。